Medical Cannabis Grower Looking to Retrofit with Heliospectra LED Lighting Solutions to Standardize Medicinal Profiles and Quality
(GOTHENBURG, Sweden/SAN FRANCISCO, CA, October 10, 2017 –
Heliospectra AB (publ) (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for greenhouse and controlled plant growth environments, announces a new cooperation with NYSK Holdings, a state-of-the-art medicinal cannabis facility in Macedonia. The grower is partnering with Heliospectra to be able to supply patients with consistent, pharmaceutical-grade medicine for chronic diseases year-round. The investment is valued at around $125,000 (1,016,000 SEK).
NYSK, a Macedonian company founded by American investors, is dedicated to producing high-quality medicinal cannabis for the Macedonian and European market. The company is retrofitting their facility and has chosen Heliospectra’s market-leading LED lighting technology to achieve consistent medicinal profiles, high-quality plants, and increased yield.
“Our state-of-the-art vertical indoor grow facility demands intense quality lighting and we know LED is the direction to go when producing high-quality crops. We conducted tests on leading LED grow light suppliers and Heliospectra gave us fantastic results on both crop quality and yield output. Heliospectra’s proven spectrum and leading control software, will allow us to produce high-quality crops and standardize medicinal profiles,” said Vancho Tolomanosi, co-owner, and founder of NYSK Holdings.
NYSK’s facility will be equipped with Heliospectra’s fully controllable LX60 series LED lights. The LX60 series is a high-quality, intense LED grow light specifically developed for full-cycle plant growth and development. It is used widely with a number of cannabis facilities demonstrating proven results.
“We are offering the most advanced solution for LED lighting which is the result of over 10 years of research and continuous development. NYSK Holdings has been looking for the LED lighting of the future. Our customer recognizes that controlling consistency and crop quality ensures a sustainable business model that can be achieved using our smart lighting solution," said Ali Ahmadian, CEO, Heliospectra.
The order will ship and be visible in the accounts during Q4
For further information, please contact:
Ali Ahmadian, CEO of Heliospectra | +46 (0)72 203 6344 | [email protected]
Redeye is Heliospectra Certified Advisor for Nasdaq First North - www.redeye.se
Heliospectra AB (publ) (OTCQB: HLSPY, FIRST NORTH: HELIO) is the industry’s most proven intelligent lighting technology for greenhouse and controlled plant growth environments. With the vision to make commercial crop production more connected and resource-efficient, growers and commercial producers across six continents use Heliospectra holistic and flexible solutions to consistently increase yields while producing crops that achieve quality appearance, superior nutritional or medicinal value and longer shelf life, harvest after harvest. Founded in 2006 and winner of multiple international awards and recognitions, Heliospectra has raised more than $32 million in capital to date. As a publicly traded company, the majority ownership remains with some of Heliospectra earliest investors Weland Steel, Swedish Industrial Fund and Midroc New Technology. For more information, please visit https://www.heliospectra.com.
The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, technical advances in the industry as well as political and economic conditions present within the industry. We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.
This information is information that Heliospectra AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 14.00 CEST / 8 AM EDT on October 10, 2017.